Bleomycin is a potent small-molecule inhibitor of hepatitis C virus replication.
Rakić
Bojana
B
The Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, K1A 0R6, Canada.
Brûlotte
Marc
M
Rouleau
Yanouchka
Y
Bélanger
Sylvie
S
Pezacki
John Paul
JP
D001761:Bleomycin / Q000494:pharmacology*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D006888:Hydroxycholesterols / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D012367:RNA, Viral / Q000378:metabolism; D012093:Replicon / Q000235:genetics; D014162:Transfection; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects*; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases; D012324:RNA-Dependent RNA Polymerase
D001761:Bleomycin; D006888:Hydroxycholesterols; D007371:Interferon-gamma; D012367:RNA, Viral; D017361:Viral Nonstructural Proteins; C084422:NS3 protein, hepatitis C virus; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases; C007997:25-hydroxycholesterol; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase